
In the double-blind clinical trial Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy…
In the double-blind clinical trial Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy…
In the study Increased reactivity of the mesolimbic reward system after ketamine injection in patients…
In the study Ketamine for Treatment-Resistant Mood Disorders, researchers underscore a pivotal turning point in…
In the clinical study titled Efficacy of ketamine therapy in the treatment of depression published…
A Promising Pattern: Meta-Analysis Reveals Strong, Sustained Antidepressant Effects of Ketamine in Treatment-Resistant Depression In…
Resetting the Circuitry: Prolonged Ketamine Infusions Show Sustained Benefits for Treatment-Resistant Depression In the open-label…
In the landmark review Ketamine and the Future of Rapid-Acting Antidepressants by Lace M. Riggs…
In the article Treatment resistant depression at a glance with traditional, first line antidepressant treatments,…
In the study Low-dose ketamine infusion in treatment-resistant double depression: Revisiting the adjunctive ketamine study…
In the study Ketamine normalizes subgenual cingulate cortex hyper-activity in depression (Morris et al., 2020),…